香港, 2024年8月24日 – (亚太商讯 via SeaPRwire.com) — 中国领先的黄金生产商–招金矿业股份有限公司(股份代号:1818,以下简称“招金矿业”或“公司”)公布截至2024年6月30日止之半年业绩。上半年,公司突出业绩导向,强化运营管理,激发经营活力,不断提升市场预判及机遇把握能…
Category: ACN Newswire
祖龙娱乐发布2024年中期业绩
财务摘要︰ – 2024年上半年收益为人民币439.4百万元,较2023年同期增长9.2%。其中,综合游戏发行及运营业务收益同比增长25.0%至人民币 376.5百万元,占总收益的85.7%。– 2024年上半年毛利为人民币321.7百万元,较2023年同期增长8.1%,毛利率为73.2%,与去…
福寿园2024年上半年在服务延展、科技引领、文化创新等领域多点发力
香港, 2024年8月24日 – (亚太商讯 via SeaPRwire.com) — 中国领先的殡葬服务提供商–福寿园国际集团有限公司(「福寿园」或「公司」,连同其附属公司,统称「集团」;股份代号:1448.HK)公布截至2024年6月30日止六个月 (「回顾期内」) 之中期业绩。 2024年…
2nd ASEAN Battery Technology Conference Strengthens Southeast Asia Battery Ecosystem Through New Collaborations and Expansion
SINGAPORE, Aug 24, 2024 – (ACN Newswire via SeaPRwire.com) – The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and […]
Kyrgyzstan Education Ministry Partners Singapore’s Marshall Cavendish Education with Plans to Adopt Singapore Maths and Science Education Titles in the Country
ISSYK KUL, Kyrgyzstan, Aug 24, 2024 – (ACN Newswire via SeaPRwire.com) – The Ministry of Education and Science of the Kyrgyz Republic has partnered with Singapore’s Marshall Cavendish Education (MCE) to introduce key training programmes and education resources to its schools throughout the country. The partnership seeks to instill key skillsets and content knowledge to strengthen […]
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Cambridge, MA, Aug 24, 2024 – (ACN Newswire via SeaPRwire.com) – Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of its COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1. “We appreciate the Ministry of […]
吉尔吉斯斯坦教育部与新加坡Marshall Cavendish教育公司合作,计划在该国采用新加坡数学和科学教育教材
吉尔吉斯斯坦伊塞克湖 , 2024年8月24日 – (亚太商讯 via SeaPRwire.com) – 吉尔吉斯共和国教育与科学部与新加坡Marshall Cavendish教育公司(MCE)合作,向全国各地的学校引入关键的培训项目和教育资源。此次合作旨在培养关键技能和知识内容,以增强教师和学…
日本厚生劳动省批准了莫德纳公司针对SARS-COV-2 JN.1变异株的COVID-19 mRNA疫苗的部分变更申请
马萨诸塞州剑桥, 2024年8月24日 – (亚太商讯 via SeaPRwire.com) – Moderna, Inc.(纳斯达克股票代码:MRNA)今日宣布,已获得日本厚生劳动省(MHLW)批准其COVID-19 mRNA疫苗Spikevax更新配方的部分变更申请,该疫苗针对SARS-Co…
骏码半导体公布中期业绩 录得收益约109.0百万港元 LED封装胶销售量再增高
香港, 2024年8月23日 – (亚太商讯 via SeaPRwire.com) — 骏码半导体材料有限公司(「骏码半导体」或「公司」,连同其附属公司统称「集团」,股份代号:8490.HK)欣然宣布截至2024年6月30日止六个月(「该期间」)之未经审核业绩。 于该期间,集团录得收益约109.0百万港元(…
AI提效显著,上市以来连续盈利,粉笔2024中期净利润增幅240.9%
香港, 2024年8月23日 – (亚太商讯 via SeaPRwire.com) — 8月23日,粉笔(02469.HK)发布2024年中期业绩报告。截至2024年6月30日,粉笔实现营收16.3亿元,与去年同期基本持平;净利润为2.8亿元,同比大涨240.9%,经调整净利润3.5亿元,同比增长21.2%…
乐普生物公布2024年中期业绩 ADC管线取得重大进展 核心产品营收大增一倍
香港, 2024年8月22日 – (亚太商讯 via SeaPRwire.com) —聚焦于肿瘤治疗领域的创新型生物制药公司──乐普生物科技股份有限公司(「乐普生物」或「公司」,股份代号:2157.HK) 公布2024年中期业绩。 作为一家立足中国、面向全球的聚焦于肿瘤治疗领域(尤其是靶向治疗及免疫治疗)的…
Weichai Power: Net profit attributable to shareholders of the parent increased by 50%
HONG KONG, Aug 23, 2024 – (ACN Newswire via SeaPRwire.com) – On 22 August 2024, Weichai Power (000338.SZ; 2338.HK) released its semi-annual report. According to the announcement, in the first half of 2024, Weichai Power achieved income of RMB 112.49 billion, a year-on-year increase of 6.0%; net profit attributable to shareholders of the parent was RMB […]
InfoComm India 2024: The Largest Edition of the Pro AV Exhibition to Date
MUMBAI, INDIA, Aug 23, 2024 – (ACN Newswire via SeaPRwire.com) – InfoComm India, India’s foremost professional audiovisual (Pro AV) exhibition, is set to return to Mumbai from 3-5 September 2024 at the Jio World Convention Centre (JWCC). This year, InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorporating Jasmine Hall (at Level […]
Web3 with Tobi & Brent to Host Exclusive Networking Event and AfterParty During Token2049 Singapore
Summary: Coinciding with F1 week and TOKEN2049 at the iconic Marina Bay Sands in Singapore, this edition of the global event series “Web3 with Tobi & Brent” will serve as a hub for the Web3 community, facilitating connections and idea exchanges among industry leaders and developers. The event will feature a headline set by renowned […]
2nd ASEAN Battery Technology Conference Announces New Collaborations and Expansion to Strengthen Southeast Asia Battery Ecosystem
SINGAPORE, Aug 23, 2024 – (ACN Newswire via SeaPRwire.com) – The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and 23rd […]
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Seoul, Korea, Aug 23, 2024 – (ACN Newswire via SeaPRwire.com) – Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024. The KBEA event, held in conjunction with the 13th Annual Biologics […]
Datacentre & Cloud Infrastructure Summit (DCCI) gears up to transform the Kingdom’s digital future
Riyadh, Saudi Arabia, Aug 22, 2024 – (ACN Newswire via SeaPRwire.com) – Having debuted in Saudi Arabia last year, Datacentre & Cloud Infrastructure Summit (DCCI) is pacing for a massive return to the country on 5 – 6 November 2024 at the luxurious JW Marriott Hotel in Riyadh. Poised to gather over 300 industry leaders, […]
Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT)
SHANGHAI, Aug 22, 2024 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalized mRNA cancer vaccine, EVM16, under the study EVM16CX01, at the Peking […]
云顶新耀宣布自主研发的新型mRNA个性化肿瘤治疗性疫苗正式启动临床试验
上海, 2024年8月22日 – (亚太商讯 via SeaPRwire.com) — 云顶新耀(HKEX 1952.HK)是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司,今日宣布正式启动一款个性化肿瘤疫苗EVM16的研究者发起的临床试验项目(IIT)EVM16CX01。该研究由北京大学肿瘤医…
赛晶科技公布2024年度中期业绩 录得总收入人民币6.56亿元 同比增长43%
2024年度中期业绩报告摘要(截至2024年6月30日止6个月) – 总收入为人民币6.56亿元,同比增加约43%;归属母公司净利润3,358万元,同比扭亏为盈。– 配输电业务方面,报告期内集团于该分领域的销售收入达人民币3.58亿元,同比大幅增长105%。其中直流输电业务同比增长177%,柔性…











